These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38890190)

  • 21. HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer.
    Verdina A; Di Segni M; Amoreo CA; Sperduti I; Buglioni S; Mottolese M; Di Rocco G; Soddu S
    Oncol Rep; 2021 Mar; 45(3):899-910. PubMed ID: 33650652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer.
    Lv Y; Zheng P; Mao Y; Xu Y; Chang W; Lin Q; Ji M; Ye L; Tang W; Xu J
    Cancer Sci; 2024 Jan; 115(1):257-269. PubMed ID: 37986654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.
    Cherradi S; Garambois V; Marines J; Andrade AF; Fauvre A; Morand O; Fargal M; Mancouri F; Ayrolles-Torro A; Vezzo-Vié N; Jarlier M; Loussaint G; Huvelle S; Joubert N; Mazard T; Gongora C; Pourquier P; Boissière-Michot F; Rio MD
    Cell Biosci; 2023 Apr; 13(1):72. PubMed ID: 37041570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis.
    Shao L; Zhu L; Su R; Yang C; Gao X; Xu Y; Wang H; Guo C; Li H
    Sci Rep; 2024 May; 14(1):10745. PubMed ID: 38730240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation.
    Meng X; Peng X; Ouyang W; Li H; Na R; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Zhuang G; Tang H; Peng Z
    Biol Proced Online; 2023 Dec; 25(1):32. PubMed ID: 38041016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.
    Shao Y; Jia H; Huang L; Li S; Wang C; Aikemu B; Yang G; Hong H; Yang X; Zhang S; Sun J; Zheng M
    Front Oncol; 2021; 11():711776. PubMed ID: 34249766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. USP11-mediated LSH deubiquitination inhibits ferroptosis in colorectal cancer through epigenetic activation of CYP24A1.
    Duan J; Huang D; Liu C; Lv Y; Zhang L; Chang F; Zeng X; Li L; Wang W; Shao G
    Cell Death Dis; 2023 Jul; 14(7):402. PubMed ID: 37414755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients.
    Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B
    Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription.
    Li SN; Yang S; Wang HQ; Hui TL; Cheng M; Zhang X; Li BK; Wang GY
    World J Gastrointest Oncol; 2024 Apr; 16(4):1564-1577. PubMed ID: 38660648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase.
    Zhan M; Ding Y; Huang S; Liu Y; Xiao J; Yu H; Lu L; Wang X
    Nat Commun; 2023 May; 14(1):3123. PubMed ID: 37253718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of targeting ferroptosis as a component of combination therapy in combating drug resistance in colorectal cancer.
    Xie XT; Pang QH; Luo LX
    World J Clin Oncol; 2024 Mar; 15(3):375-377. PubMed ID: 38576594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights on Ferroptosis and Colorectal Cancer: Progress and Updates.
    Hu B; Yin Y; Li S; Guo X
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
    Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
    EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxaliplatin induces ferroptosis and oxidative stress in HT29 colorectal cancer cells by inhibiting the Nrf2 signaling pathway.
    Liu B; Wang H
    Exp Ther Med; 2022 Jun; 23(6):394. PubMed ID: 35495610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase.
    Zhou Y; Wan G; Spizzo R; Ivan C; Mathur R; Hu X; Ye X; Lu J; Fan F; Xia L; Calin GA; Ellis LM; Lu X
    Mol Oncol; 2014 Feb; 8(1):83-92. PubMed ID: 24145123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.
    Yang J; Mo J; Dai J; Ye C; Cen W; Zheng X; Jiang L; Ye L
    Cell Death Dis; 2021 Nov; 12(11):1079. PubMed ID: 34775496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer.
    Wu W; Zhao Y; Qin B; Jiang X; Wang C; Hu R; Ma R; Lee MH; Liu H; Li K; Yuan P
    EBioMedicine; 2023 Jul; 93():104650. PubMed ID: 37343364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer.
    Izumi D; Toden S; Ureta E; Ishimoto T; Baba H; Goel A
    Cell Death Dis; 2019 Mar; 10(4):267. PubMed ID: 30890693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.